Andrew Goldsweig to Ischemia
This is a "connection" page, showing publications Andrew Goldsweig has written about Ischemia.
Connection Strength
0.398
-
Goldsweig AM, Deng Y, Yao X, Desai NR, Cohen DJ, Aronow HD, Mess? SR, Ross JS, Lansky AJ, Savitz ST. Approval, Evidence, and "Off-Label" Device Utilization: The Patent Foramen Ovale Closure Story. Circ Cardiovasc Qual Outcomes. 2024 01; 17(1):e010200.
Score: 0.196
-
Altin SE, Kim YG, Aronow HD, Armstrong EJ, Goldsweig AM, Dardik A, Lanksy AJ, Mena-Hurtado CI, Abbott JD. Seasonal variation in U.S. hospitalizations for chronic limb-threatening ischemia. Catheter Cardiovasc Interv. 2020 12; 96(7):1473-1480.
Score: 0.156
-
Carson JL, Brooks MM, Chaitman BR, Alexander JH, Goodman SG, Bertolet M, Abbott JD, Cooper HA, Rao SV, Triulzi DJ, Fergusson DA, Kostis WJ, Noveck H, Simon T, Steg PG, DeFilippis AP, Goldsweig AM, Lopes RD, White H, Alsweiler C, Morton E, H?bert PC. Rationale and design for the myocardial ischemia and transfusion (MINT) randomized clinical trial. Am Heart J. 2023 03; 257:120-129.
Score: 0.045